Johnson & Johnson Services & Gilead Sciences, Inc. – Notable Market Players in Liposome Drug Delivery Market
Liposomes contain an aqueous solution core that is surrounded by a hydrophobic membrane as a lipid bilayer. The liposomes work by delivering the drug by diffusion than that of direct cell fusion. These biomolecules are emerging in drug delivery systems as they improve therapeutic index of the established as well as new drugs by modifying the drug absorption, reducing the metabolism and prolonging their biological half-life through reduced toxicity.
Market leaders operating in the market have undertaken various inorganic and organic growth strategies in the liposome drug delivery market. The liposome drug delivery market majorly consists of the players such as Takeda Pharmaceutical Company Limited, Novartis AG, Luye Pharma Group, Ipsen Pharma, CELSION, Inc., Gilead Sciences, Inc., Astellas Pharma, Inc., Johnson & Johnson Services, Inc., Pacira Biosciences, Inc. and Acrotech Biopharma, Inc. Inorganic growth strategies witnessed in the market such as partnerships, collaboration, and mergers & acquisitions have paved way for expansion of business and customer base of market players
Below is the list of the growth strategies done by the players operating in the liposome drug delivery market:
|
Year |
News |
|
April, 2019 |
Luye Pharma’s Lipusu, an innovative paclitaxel liposome formulation was included and approved as a first-line drug for non-squamous cell carcinoma in the Chinese Society of Clinical Oncology (CSCO) Guidelines |
|
April, 2019 |
Ipsen Pharma completed acquisition of global oncology assets from Merrimack Pharmaceuticals, in Cambridge that focuses on ONIVYDE (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. |
|
March, 2019 |
Acrotech Biopharma L.L.C., a step-down subsidiary of Aurobindo Pharma Limited, India completed acquisition of seven FDA-approved hematology/oncology products Spectrum Pharmaceuticals, Inc. One of the seven products include MARQIBO (vinCRIStine sulfate LIPOSOME injection) |
